Skip to main content
Fig. 6 | BMC Bioinformatics

Fig. 6

From: Development and validation of the potential biomarkers based on m6A-related lncRNAs for the predictions of overall survival in the lung adenocarcinoma and differential analysis with cuproptosis

Fig. 6

Heatmap analysis of the two risk sets in all patients.The figure shows that the differences of patient with N stage, T stage, Stage, Sex, Immune Score, and Cluster was respectively significant in two risk sets. The heatmap also shows the expression of the 10 prognostic m6A-related lncRNAs in the two risk sets.lncRNA, long non-coding RNA.“***”: P < 0.001, “**”: P < 0.01, “*”: P < 0.05

Back to article page